Glycine reuptake inhibitor
A glycine reuptake inhibitor (GRI) is a type of drug which inhibits the reuptake of the neurotransmitter glycine by blocking one or more of the glycine transporters (GlyTs). Examples of GRIs include bitopertin (RG1678), ORG-24598, ORG-25935, ALX-5407, and sarcosine, which are selective GlyT1 blockers, and ORG-25435 and N-arachidonylglycine, which are selective GlyT2 blockers.[1][2] Some weak and/or non-selective GlyT blockers include amoxapine and ethanol (alcohol).[3]
See also
- Reuptake inhibitor
- Glycinergic
- GABA reuptake inhibitor
- Excitatory amino acid reuptake inhibitor
References
- ^ Harsing LG, Juranyi Z, Gacsalyi I, Tapolcsanyi P, Czompa A, Matyus P (2006). "Glycine transporter type-1 and its inhibitors". Curr. Med. Chem. 13 (9): 1017–44. doi:10.2174/092986706776360932. PMID 16611082.
- ^ Harvey RJ, Yee BK (November 2013). "Glycine transporters as novel therapeutic targets in schizophrenia, alcohol dependence and pain". Nat Rev Drug Discov. 12 (11): 866–85. doi:10.1038/nrd3893. PMID 24172334. S2CID 28022131.
- ^ Harald Sitte, Michael Freissmuth (2 August 2006). Neurotransmitter Transporters. Springer Science & Business Media. pp. 472–. ISBN 978-3-540-29784-0.
- v
- t
- e
Glycine receptor modulators
(ligands)
(blockers)
GlyT1Tooltip Glycine transporter 1 |
|
---|---|
GlyT2Tooltip Glycine transporter 2 |
|
- See also
- Receptor/signaling modulators
- GABA receptor modulators
- GABAA receptor positive modulators
- Ionotropic glutamate receptor modulators
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e